ArticleCancers2020

Therapeutic Efficacy of ABN401, a Highly Potent and Selective MET Inhibitor, Based on Diagnostic Biomarker Test in

Jooseok Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.